Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,709 | 2,616 | -3,986 | -19,352 | -14,399 |
| Depreciation Amortization | 218 | 70 | 34 | 297 | 222 |
| Other Working Capital | -1,855 | -3,285 | -856 | -1,122 | -1,532 |
| Other Operating Activity | 1,090 | 861 | 567 | 1,295 | 1,047 |
| Operating Cash Flow | $-3,256 | $262 | $-4,241 | $-18,882 | $-14,662 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,173 | 2,869 | 11,104 | 21,432 | 16,129 |
| PPE Investments | -14 | -14 | -2 | N/A | N/A |
| Investing Cash Flow | $-8,187 | $2,855 | $11,102 | $21,432 | $16,129 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18,715 | 9,683 | N/A | 1,313 | 1,038 |
| Other Financing Activity | -148 | -148 | -148 | -130 | -130 |
| Financing Cash Flow | $18,567 | $9,535 | $-148 | $1,183 | $908 |
| Beginning Cash Position | 14,032 | 14,032 | 14,032 | 10,299 | 10,299 |
| End Cash Position | 21,156 | 26,684 | 20,745 | 14,032 | 12,674 |
| Net Cash Flow | $7,124 | $12,652 | $6,713 | $3,733 | $2,375 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,256 | 262 | -4,241 | -18,882 | -14,662 |
| Capital Expenditure | -14 | -14 | -2 | N/A | N/A |
| Free Cash Flow | -3,270 | 248 | -4,243 | -18,882 | -14,662 |